Hongyuan Cao

Dr. Hongyuan Cao

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Bioinformatics
Verified
Journal Article
Open access
PDF file
PLPengfei Lyu
Pengfei Lyu
YLYan Li
Yan Li
XWXiaoquan Wen
Xiaoquan Wen
Hongyuan CaoHongyuan Cao
Hongyuan Cao
Replicability is the cornerstone of scientific research. The current statistical method for high-dimensional replicability analysis either cannot control the false discovery rate (FDR) or is too conservative. We propose a statistical method, JUMP, for the high-dimensional replicability analysis of two studies. The input is a high-dimensional paired sequence of p-values from two studies and the test statistic is the maximum of p-values of the pair. JUMP uses four states of the p-value pairs to indicate whether they are null or non-null. Conditional on the hidden states, JUMP computes the cumulative distribution function of the maximum of p-values for each state to conservatively approximate the probability of rejection under the composite null of replicability. JUMP estimates unknown parameters and uses a step-up procedure to control FDR. By incorporating different states of composite null, JUMP achieves a substantial power gain over existing methods while controlling the FDR. Analyzing two pairs of spatially resolved transcriptomic datasets, JUMP makes biological discoveries that otherwise cannot be obtained by using existing methods. An R package JUMP implementing the JUMP method is available on CRAN (https://CRAN.R-project.org/package=JUMP).

9 November 2019 in Annals of the Institute of Statistical Mathematics
Verified
Journal Article
Closed access
PDF file
Hongyuan CaoHongyuan Cao
Hongyuan Cao
JFJason P. Fine
Jason P. Fine

11 February 2022 in Lifetime Data Analysis
Verified
Journal Article
Closed access
PDF file
ZSZhuowei Sun
Zhuowei Sun
Hongyuan CaoHongyuan Cao
Hongyuan Cao
LCLi Chen
Li Chen

16 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
FJFelix Johnson
Felix Johnson
NBNora-Maria Burian
Nora-Maria Burian
MSMatthias Santer
Matthias Santer
VSVerena Strasser
Verena Strasser
TSTeresa Bernadette Steinbichler
Teresa Bernadette Steinbichler
ABAmir Bolooki
Amir Bolooki
Introduction: Salivary gland tumor operations are associated with complications including facial nerve dysfunction (FND) and salivary fistula. The objective of this study was to investigate the effect of extracapsular dissection (ECD) and the application of Clostridium botulinum toxin (CBT) in contrast to partial and lateral parotidectomy on complications. Methods: All salivary gland tumor operations performed within the last 6 years were retrospectively examined. Data were collected from electronic patient files from our otorhinolaryngology clinic. Total parotidectomies and submandibulectomies were not included in the analysis of CBT application. Results: In total, 418 cases were examined, including 84 (20%) malignant tumors. In total, 18 patients underwent ECD, 93 partial parotidectomy, 199 lateral parotidectomy, 76 total parotidectomy, and 32 submandibulectomy. The most common complication was transient FND (49%; n = 205; data available for 415 patients), which was measured at four days. Additional complications included salivary fistula (n = 56), infection (n = 49), bleeding or hematoma (n = 21). Preoperative facial nerve paralysis (p < 0.0001), pain (p < 0.0001), and a history of squamous cell skin carcinoma (SCC) (p < 0.001) were predictive of malignancy. The application of CBT did not reduce the risk of salivary fistula (p-value: 0.0182) and was associated with a higher combined complication rate (p-value: 0.0199). ECD was not associated with a lower likelihood for FND (p = 0.350). Conclusions: Preoperative pain, facial paralysis, or a history of SCC are predictors of malignancy. Use of CBT was not associated with a reduced risk of salivary fistula, but rather a higher complication rate.

2 May 2024 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
YLYan Li
Yan Li
HLHaochen Lei
Haochen Lei
XWXiaoquan Wen
Xiaoquan Wen
Hongyuan CaoHongyuan Cao
Hongyuan Cao

3 October 2024 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
YLYan Li
Yan Li
XZXiang Zhou
Xiang Zhou
RCRui Chen
Rui Chen
XZXianyang Zhang
Xianyang Zhang
Hongyuan CaoHongyuan Cao
Hongyuan Cao
Replicable signals from different yet conceptually related studies provide stronger scientific evidence and more powerful inference. We introduce STAREG, a statistical method for replicability analysis of high throughput experiments, and apply it to analyze spatial transcriptomic studies. STAREG uses summary statistics from multiple studies of high throughput experiments and models the the joint distribution of p-values accounting for the heterogeneity of different studies. It effectively controls the false discovery rate (FDR) and has higher power by information borrowing. Moreover, it provides different rankings of important genes. With the EM algorithm in combination with pool-adjacent-violator-algorithm (PAVA), STAREG is scalable to datasets with millions of genes without any tuning parameters. Analyzing two pairs of spatially resolved transcriptomic datasets, we are able to make biological discoveries that otherwise cannot be obtained by using existing methods.